Sierra Medical Secures Over RMB 100 Million in New Funding and to Showcase Portfolio at National Ophthalmology Annual Meeting

Following its billion-yuan financing in 2024, Sierra Medical, a leading innovator in ophthalmic medical devices in China, has once again gained favor in the capital market and recently announcedCompleted a new round of financing exceeding 100 million yuanThis round of financing was jointly led by Qianji Capital and Shunwei Capital, with continued support from existing shareholders Boxin Capital and H&Z Fund.Sierra Medical completed a multi-million Pre-A round of financing led by Apricot Capital in 2023.

The funds from this round of financing will be mainly used forIn-depth R&D Advancement of Sierra Medical's First Self-developed Phacoemulsification and Vitrectomy Integrated Product Line, while further enriching the company's ophthalmic surgical equipment product portfolio, accelerating the import substitution of high-end domestically produced ophthalmic devices and the overseas expansion of the company's ophthalmic products.

The successful completion of this round of financing not only reflects the investors' high recognition of Sierra Medical's innovative strength and development prospects, but also injects strong momentum into the company's next stage of development.

Industry Gala Makes a Stunning Debut

It is worth mentioning that Sierra Medical is about to participate in the event held in Hangzhou from September 4-7, 2025.National Ophthalmology Annual Meeting。At this industry event, Sierra Medical will make a stunning appearance with its flagship products, including those already on the market.China's First NEXVIT with a Cutting Speed of up to 20,000 Times Per Minute^®Full Series of Ultra-High-Speed Dual-Blade Dual-Airflow Vitrectomy Heads and Single-Use Trocars，including the upcoming blockbuster series of products: laser fibers, phacoemulsification and vitrectomy machines, phacoemulsification machines, and related配套耗材.

For the ophthalmologists and industry professionals attending, this will be an opportunity to directly engage with and evaluate the performance of related products, while also providing a scenario to observe the clinical implementation of domestically produced ophthalmic devices.

Sierra Medical sincerely invites people from all walks of life to visit and discuss, jointly promoting the development of ophthalmic medical services.

In the field of ophthalmic surgical equipment, the domestic market in China has long relied on imported brands. Sierra Medical, with its independent core technology, is gradually breaking this situation. Sierra Medical was foundedIn July 2022, the company's core team has rich industry experience and possesses complete R&D, production, and commercialization capabilities. The company focuses on providing precise, intelligent, minimally invasive surgical treatment solutions for ophthalmology, aiming to break the monopoly of foreign enterprises in the high-end ophthalmic surgical instruments field and resolve the "bottleneck" issue of critical surgical instruments. Currently, its products under development mainly include phacoemulsification and vitrectomy integrated machines and their supporting consumables, digital surgical microscopes, and other high-end ophthalmic surgical instruments. Sierra Medical is committed to providing innovative and high-quality products and services to ophthalmologists and patients, promoting the advancement of ophthalmic medical technology.